Antonio Giménez-Gaibar

Antonio Giménez-Gaibar

Auto-generated profile, based on publicly available information

Antonio Giménez-Gaibar

Servicio de Cirugía Vascular, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Barcelona, España

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Nefrología
Verified
Journal Article
Open access
JIJosé Ibeas
José Ibeas
RRRamon Roca-Tey
Ramon Roca-Tey
JVJoaquín Vallespín
Joaquín Vallespín
TMTeresa Moreno
Teresa Moreno
GMGuillermo Moñux
Guillermo Moñux
ÁBÁngel Barba
Ángel Barba
Vascular access for haemodialysis is key in renal patients both due to its associated morbidity and mortality and due to its impact on quality of life. The process, from the creation and maintenance of vascular access to the treatment of its complications, represents a challenge when it comes to decision-making, due to the complexity of the existing disease and the diversity of the specialities involved. With a view to finding a common approach, the Spanish Multidisciplinary Group on Vascular Access (GEMAV), which includes experts from the five scientific societies involved (nephrology [S.E.N.], vascular surgery [SEACV], vascular and interventional radiology [SERAM-SERVEI], infectious diseases [SEIMC] and nephrology nursing [SEDEN]), along with the methodological support of the Cochrane Center, has updated the Guidelines on Vascular Access for Haemodialysis, published in 2005. These guidelines maintain a similar structure, in that they review the evidence without compromising the educational aspects. However, on one hand, they provide an update to methodology development following the guidelines of the GRADE system in order to translate this systematic review of evidence into recommendations that facilitate decision-making in routine clinical practice, and, on the other hand, the guidelines establish quality indicators which make it possible to monitor the quality of healthcare.

1 October 2020 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PTPaolo Tripodi
Paolo Tripodi
GMGaspar Mestres
Gaspar Mestres
VRVicente Riambau
Vicente Riambau
ACAlbert Clarà
Albert Clarà
JDJaume Dilme
Jaume Dilme
CCCristina Casanovas-Guitart
Cristina Casanovas-Guitart

1 January 2021 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
ECElena González Cañas
Elena González Cañas
SLSalvador Florit López
Salvador Florit López
RVRoser Vives Vilagut
Roser Vives Vilagut
KGKerbi Alejandro Guevara-Noriega
Kerbi Alejandro Guevara-Noriega
MEMarta Santos Espí
Marta Santos Espí
AGAntonio Giménez Gaibar
Antonio Giménez Gaibar

5 August 2020 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
ECE. Gonzalez Cañas
E. Gonzalez Cañas
AGA. Gimenez Gaibar
A. Gimenez Gaibar
LLL. Rodriguez Lorenzo
L. Rodriguez Lorenzo
JRJ. G. Castro Rios
J. G. Castro Rios
ATA. Martinez Toiran
A. Martinez Toiran
MSM. Espasa Soley
M. Espasa Soley
Click on the article title to read more.

1 November 2017 in Annals of Vascular Surgery
Verified
Journal Article
Open access
ICIan Chetter
Ian Chetter
GSGerard Stansby
Gerard Stansby
JSJosé Aurelio Sarralde
José Aurelio Sarralde
VRVicente Riambau
Vicente Riambau
AGAntonio Giménez-Gaibar
Antonio Giménez-Gaibar
JNJordi Navarro-Puerto
Jordi Navarro-Puerto
Anastomotic or "stitch hole" bleeding is common during vascular surgery with synthetic material such as Dacron or polytetrafluoroethylene. Hemostatic adjuncts such as fibrin sealant (FS) may reduce blood loss and operating time in such circumstances. We evaluated the safety and the hemostatic effectiveness of a ready-to-use human plasma-derived FS in vascular surgery. Patients with mild/moderate suture line bleeding during elective, open, vascular surgery using synthetic grafts or patches were studied. In an initial Exploratory Study, all patients were treated with FS Grifols, and in a subsequent Primary Study were randomized in a 2:1 ratio to FS Grifols or manual compression (MC). The primary efficacy end point was time to hemostasis (TTH), assessed at defined intervals from the start of treatment application, during a 10-min observational period. Safety end points (in Exploratory + Primary Studies) included adverse events (AEs), vital signs, physical assessments, common clinical laboratory tests (coagulation, complete blood count, serum clinical chemistry parameters, microscopic urinalysis), viral markers, and immunogenicity. In the Primary Study, the proportion of patients who achieved hemostasis at the 3-min time point was higher in the FS Grifols group (46.4%, n = 51/110) than in the MC group (26.3%, n = 15/57) (P < 0.05). The benefit was maintained at successive time intervals: 69 FS Grifols patients (62.7%) and 18 MC patients (31.6%) at 4 min; 82 FS Grifols patients (74.5%) and 28 MC patients (49.1%) at 5 min. The differences between the groups persisted for TTH ≤ 7 min and TTH ≤ 10 min. Treatment failure was reported for 13 FS Grifols patients (11.8%) and 16 MC patients (28.1%). TTH was shorter after FS Grifols application than after MC application. Differences were statistically significant in favor of FS Grifols for each TTH category and for the overall comparison (P < 0.001) as well as for each TTH category (cumulative) and for treatment failure (P = 0.016). Overall, AE experience and types of AEs reported were those expected in this patient population and were similar between the 2 treatment groups. The most frequently reported AEs were procedural pain (59.9% and 69.2% of patients in the FS Grifols [n = 72 + 111] and MC [n = 57] groups, respectively) and nausea (23.5% and 19.2% of patients, respectively). FS Grifols was efficacious and safe as an adjunct to anastomotic hemostasis in patients undergoing arterial surgery using prosthetic material with mild to moderate bleeding.

1 August 2017 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
AGAntonio Giménez-Gaibar
Antonio Giménez-Gaibar
EGElena González-Cañas
Elena González-Cañas
TSTeresa Solanich-Valldaura
Teresa Solanich-Valldaura
CHCarolina Herranz-Pinilla
Carolina Herranz-Pinilla
SRSara Rioja-Artal
Sara Rioja-Artal
EFElisabeth Ferraz-Huguet
Elisabeth Ferraz-Huguet